V Petronilli Selected Research

1,9-dideoxyforskolin

3/2004

Apoptosis to necrosis switching downstream of apoptosome formation requires inhibition of both glycolysis and oxidative phosphorylation in a BCL-X(L)- and PKB/AKT-independent fashion.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

V Petronilli Research Topics

Disease

2	Heart Failure 01/2022 - 09/2021
2	Hepatocellular Carcinoma (Hepatoma) 04/2001 - 04/2001
1	Cardiotoxicity 01/2020
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2020
1	Neoplasms (Cancer) 01/2020
1	Sarcoma (Soft Tissue Sarcoma) 01/2020
1	Obesity 08/2008
1	Mitochondrial Diseases (Mitochondrial Disease) 02/2007
1	Necrosis 03/2004

Drug/Important Bio-Agent (IBA)

2	sacubitril and valsartan sodium hydrate drug combinationIBA 01/2022 - 09/2021
2	Adenosine Triphosphate (ATP)IBA 02/2007 - 03/2004
2	Cytochromes c (Cytochrome c)IBA 02/2007 - 04/2001
1	AnthracyclinesIBA 01/2020
1	Dexrazoxane (Zinecard)FDA LinkGeneric 01/2020
1	Peptidyl-Prolyl Isomerase FIBA 08/2008
1	IonophoresIBA 02/2007
1	Calcimycin (A23187)IBA 02/2007
1	ColforsinIBA 03/2004
1	Apoptosomes (Apoptosome)IBA 03/2004
1	Adenylyl Cyclases (Adenylyl Cyclase)IBA 03/2004
1	1,9-dideoxyforskolinIBA 03/2004
1	Palmitic AcidsIBA 04/2001

Therapy/Procedure

2	Implantable Defibrillators (Implantable Cardioverter-Defibrillator) 01/2022 - 09/2021
1	Defibrillators (Defibrillator) 09/2021
1	Therapeutics 09/2021